Acumen Hypotension Prediction Index – EV1000 Clinical Platform vs Acumen Hypotension Prediction Index (HPI) Feature Software

Direct competitors — feature-level head-to-head below. Comparability 95/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

AI Verdict

These two entries describe the same core product, the Acumen Hypotension Prediction Index (HPI) software by Edwards Lifesciences. Both leverage machine learning to predict hypotensive events up to 15 minutes in advance, providing clinicians with hemodynamic insights and alerts. The slight variations in naming and feature descriptions likely reflect different product iterations or marketing emphasis for the same underlying technology integrated with the HemoSphere advanced monitoring platform.

Choose Acumen Hypotension Prediction Index – EV1000 Clinical Platform if…

Choose this tool if your clinical environment primarily utilizes the Edwards Lifesciences HemoSphere Advanced Monitoring Platform (or previously EV1000 Clinical Platform) and you prioritize non-invasive or minimally-invasive hemodynamic monitoring. It is ideal for proactive hypotension management using dedicated Acumen IQ cuff or sensor technology to predict events up to 15 minutes in advance.

View Acumen Hypotension Prediction Index – EV1000 Clinical Platform →

Choose Acumen Hypotension Prediction Index (HPI) Feature Software if…

Choose this tool if your clinical practice requires flexible hemodynamic monitoring options, including both invasive arterial line and non-invasive Acumen IQ cuff compatibility, within the HemoSphere advanced monitoring platform. This feature software is particularly well-suited for settings where an adjustable Mean Arterial Pressure (MAP) target is critical for individualized patient care and where a demonstrated reduction in intraoperative hypotension is a key objective.

View Acumen Hypotension Prediction Index (HPI) Feature Software →

Both Acumen Hypotension Prediction Index (HPI) tools from Edwards Lifesciences leverage machine learning to predict hypotensive events up to 15 minutes in advance, offering a 0-100 likelihood score and insights into hemodynamic instability. They share core features like Smart Alerts, Smart Trend, and Relationship View screens, providing data on preload, afterload, and contractility. Both are designed for specialties such as Anesthesiology, Critical Care, and Emergency Medicine, and are HIPAA compliant with FDA clearance.

The key practical difference lies in their deployment and associated hardware. The Acumen Hypotension Prediction Index – EV1000 Clinical Platform is integrated with the HemoSphere Advanced Monitoring Platform (and previously EV1000 Clinical Platform) via dedicated sensors (Acumen IQ cuff or sensor). In contrast, the Acumen Hypotension Prediction Index (HPI) Feature Software is described as a feature integrated into the HemoSphere advanced monitoring platform. This suggests the EV1000 Clinical Platform offering might be a more comprehensive solution encompassing both the software and specific hardware for data acquisition, while the Feature Software could be an add-on to an existing HemoSphere setup.

A physician choosing between these should consider their current monitoring infrastructure. If a practice is establishing new advanced hemodynamic monitoring capabilities or upgrading an older EV1000 system, the Acumen Hypotension Prediction Index – EV1000 Clinical Platform might be the more suitable choice, providing a complete hardware and software solution. Conversely, if a physician already utilizes the HemoSphere advanced monitoring platform, the Acumen Hypotension Prediction Index (HPI) Feature Software would likely be the more direct and cost-effective option to integrate predictive hypotension capabilities into their existing system.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Acumen Hypotension Prediction Index – EV1000 Clinical Platform Acumen Hypotension Prediction Index (HPI) Feature Software
Pricing Contact-for-pricing Contact vendor
Deployment Integrated with Edwards Lifesciences HemoSphere Advanced Monitoring Platform (and previously EV1000 Clinical Platform) via dedicated sensors (Acumen IQ cuff or sensor). Integrated into Edwards Lifesciences HemoSphere advanced monitoring platform.
FDA Status 1 AI-estimated 1 AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Acumen Hypotension Prediction Index (HPI) Feature Software

Both tools integrate into the Edwards Lifesciences monitoring ecosystem and offer similar user interface elements like HPI scores and smart alerts. However, Tool B explicitly highlights an 'Adjustable Mean Arterial Pressure (MAP) target,' which provides clinicians with greater flexibility and customization, potentially enhancing its usability in varied clinical contexts.

Clinical Value

Acumen Hypotension Prediction Index (HPI) Feature Software

While both tools aim to predict and manage hypotension, Tool B explicitly states a 'demonstrated reduction in incidence, duration, and severity of intraoperative hypotension.' This direct claim of improved patient outcomes provides a stronger indication of clinical value compared to Tool A's more general statement about helping to reduce hypotension.

Pricing & Value

Tie

Both Tool A and Tool B are products from Edwards Lifesciences and share the same non-transparent pricing model, requiring direct contact with the vendor for information. Without access to specific pricing details or differentiated value propositions, it is impossible to determine a winner in this dimension.

Enterprise Readiness

Acumen Hypotension Prediction Index (HPI) Feature Software

Both tools demonstrate strong enterprise readiness through FDA clearance and HIPAA compliance, and integration with the Edwards Lifesciences HemoSphere platform. However, Tool B explicitly states it 'has_baa' (Business Associate Agreement), which is a crucial element for data privacy and compliance in enterprise healthcare deployments.

Innovation

Tie

Both Tool A and Tool B represent the same core innovation: a machine learning-based algorithm for predicting hypotensive events up to 15 minutes in advance. As they are fundamentally the same product from the same company, there is no discernible difference in their innovative aspects.

Support & Docs

Tie

Both tools are components of the Edwards Lifesciences HemoSphere advanced monitoring platform, implying they share the same comprehensive support and documentation resources provided by the manufacturer. These resources include operator's manuals, setup guides, and 24/7 technical support, making it impossible to distinguish between the two on this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Acumen Hypotension Prediction Index – EV1000 Clinical Platform Acumen Hypotension Prediction Index (HPI) Feature Software
Product Name Acumen Hypotension Prediction Index u2013 EV1000 Clinical Platform Acumen Hypotension Prediction Index (HPI) Feature Software
Company Edwards Lifesciences Edwards Lifesciences
Tagline Predicting and managing hypotension before it occurs. A first-of-its-kind technology that detects and helps clinicians treat hemodynamic instability.
Prediction Horizon Predicts hypotension up to 15 minutes in advance Predicts hypotension up to 15 minutes before an event
Core Prediction Metric HPI Parameter (0-100 likelihood score) Hypotension Prediction Index (HPI) parameter (0-100 score)
Supported Monitoring Modalities Non-invasive (Acumen IQ cuff) and minimally-invasive (Acumen IQ sensor) options Compatibility with both invasive (arterial line) and non-invasive (Acumen IQ cuff) monitoring

Videos

Demos, reviews, and walkthroughs featuring Acumen Hypotension Prediction Index – EV1000 Clinical Platform and Acumen Hypotension Prediction Index (HPI) Feature Software.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Tool B explicitly highlights a 'demonstrated reduction in incidence, duration, and severity of intraoperative hypotension,' providing a direct claim of proven clinical impact. Both tools leverage the Acumen HPI software, which has been shown in clinical studies to reduce the duration of intraoperative hypotension.
Tool B explicitly states an 'Adjustable Mean Arterial Pressure (MAP) target for hypotension definition.' The underlying Acumen HPI software allows customization of the MAP target (e.g., 55, 60, 70, 75, 80, 85 mmHg) in addition to the default 65 mmHg, providing flexibility for clinical protocols.
Tool A supports non-invasive (Acumen IQ cuff) and minimally-invasive (Acumen IQ sensor) options. Tool B specifies compatibility with both invasive (arterial line) and non-invasive (Acumen IQ cuff) monitoring, indicating comprehensive support for various data sources.
Both tools integrate with the Edwards Lifesciences HemoSphere advanced monitoring platform. The provided information does not detail direct integration capabilities with broader hospital EHR systems for automated data transfer beyond this monitoring platform.
Given that both tools utilize the same core Acumen HPI software with similar interfaces like Smart Alerts and Relationship View, the learning curve should be comparable. Edwards Lifesciences offers clinical education and resources to support users throughout their learning process.
AI Tool Finder
AI-powered search. Results may not be comprehensive.